Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Ten-year experience with cryopreserved vascular allografts in the Croatian Cardiovascular Tissue Bank (CROSBI ID 314346)

Prilog u časopisu | izvorni znanstveni rad

Golemović, Mirna ; Škifić, Marijana ; Halužan, Damir ; Pavić, Predrag ; Golubić Ćepulić, Branka Ten-year experience with cryopreserved vascular allografts in the Croatian Cardiovascular Tissue Bank // CELL AND TISSUE BANKING, 23 (2022), 4; 807-824. doi: 10.1007/s10561-022-09992-6

Podaci o odgovornosti

Golemović, Mirna ; Škifić, Marijana ; Halužan, Damir ; Pavić, Predrag ; Golubić Ćepulić, Branka

engleski

Ten-year experience with cryopreserved vascular allografts in the Croatian Cardiovascular Tissue Bank

The Croatian Cardiovascular Tissue Bank (CTB) was established in June 2011. Activities managed by CTB are processing of heart valves and blood vessels, as well as quality control, storage, medical release and distribution of allografts. The aim of this report is to present CTB's vascular tissue activities and retrospectively evaluate the outcomes of their use in the University Hospital Centre Zagreb. Between June 2011 and July 2021, 90 vascular allografts (VAs) from 55 donors after brain death were referred to CTB. Only 54% of VAs met the tissue quality requirements while 46% of tissues were discarded. The most frequent reasons for discard were unacceptable morphology and initial microbiological contamination. Altogether 42 VAs were released for transplantation and 37 of them were used in 27 surgical procedures. The most common indication for surgery was prosthetic graft or stent infection. According to the anatomic position of vascular reconstruction, patients were divided in the aortic and peripheral reconstruction group. A total of 23 patients were treated. In the aortic reconstruction group 58% of patients did not experience any graft-related complications. In the group of patients who underwent peripheral reconstruction significant incidence of reinfection was observed highlighting it as a major graft-related complication. Despite the small patient groups and limited duration of follow-up, presented clinical outcomes provide valuable information on the efficacy of vascular allografts. Additional clinical results collected on a larger patient groups and comparison to other reconstructive treatment options are necessary.

aortic reconstruction ; peripheral reconstruction ; tissue bank ; vascular allografts

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

23 (4)

2022.

807-824

objavljeno

1389-9333

1573-6814

10.1007/s10561-022-09992-6

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

Poveznice
Indeksiranost